RJ7-39142-39846 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-24
Registered in v-safe
2022-06-28
Dose 1 — Pfizer-BioNTech
2022-07-23
Dose 2 — Pfizer-BioNTech
2022-10-01
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2022-10-28
Health check-in — day 21, dose 3, dependent
Feeling: Good

Adult check-in
2022-10-29
Health check-in — day 28, dose 3, dependent
Feeling: Good

Adult check-in
2022-11-05
Health check-in — day 35, dose 3, dependent
Feeling: Good

Adult check-in
2022-11-12
Health check-in — day 42, dose 3, dependent
Feeling: Good

Adult check-in
2023-01-03
Survey response — 3 months, dose 3, dependent
MedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: Good · Be unable to work or attend school

MedDRA releases: 2024-11
2023-04-05
Survey response — 6 months, dose 3, dependent
MedDRA: Surgery, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional

MedDRA releases: 2024-11
2023-04-05
Report sent to call center — 6 months, dose 3, dependent
Get care from a doctor or other healthcare professional

1 call case(s)
2023-04-06
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-28	Pfizer-BioNTech	No
2	2022-07-23	Pfizer-BioNTech	No
3	2022-10-01	Pfizer-BioNTech	Flu

Call center

Reported	Outcome	VAERS-related outcome
2023-04-05	Unsuccessful

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Surgery	·	·	✓
SD	Cough	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	Unevaluable event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release